Author: Dr.Poonam Sharma

Until recently, glucagon-like peptide-1 (GLP-1) receptor agonists were known primarily as a treatment for type 2 diabetes. But today, these drugs have transformed into a major player in weight loss therapy. Moreover, they are on the verge of reshaping the entire healthcare landscape. From treating obesity to possibly impacting neurodegenerative diseases and addiction disorders, the…

Over the last few years, much attention has been given to insulin and its role in blood sugar management. But equally important (and often overlooked) is glucagon, a hormone that works in tandem with insulin to regulate the body’s glucose balance. Today, the scientific community and public health experts are paying renewed attention to glucagon,…

In recent years, there has been a growing wave of curiosity around glucagon, the lesser-known counterpart to insulin. While insulin often gets the spotlight in conversations about blood sugar, glucagon quietly does the work behind the scenes to ensure your body has enough glucose during fasting, exercise, or low sugar levels. This balance between insulin…

Over the past few years, GLP-1 agonist medications have rapidly gained attention in both medical communities and on social platforms. Once reserved mainly for type 2 diabetes treatment, these drugs are now being discussed as promising tools for weight loss. In India and globally, people are increasingly asking their doctors about “GLP 1,” searching for…

What if you could give your weight loss journey a boost? GLP-1 receptor agonists are doctor-prescribed medications that facilitate weight loss by replicating a hormone that curbs your appetite. Their effectiveness is amplified when paired with consistent physical activity, balanced nutrition, and overall healthy lifestyle choices. By integrating GLP-1 into a comprehensive, holistic health plan…